Literature DB >> 23535362

Specific pesticide-dependent increases in α-synuclein levels in human neuroblastoma (SH-SY5Y) and melanoma (SK-MEL-2) cell lines.

Areski Chorfa1, Dominique Bétemps, Eric Morignat, Corinne Lazizzera, Kevin Hogeveen, Thibault Andrieu, Thierry Baron.   

Abstract

Epidemiological studies indicate a role of genetic and environmental factors in Parkinson's disease involving alterations of the neuronal α-synuclein (α-syn) protein. In particular, a relationship between Parkinson's disease and occupational exposure to pesticides has been repeatedly suggested. Our objective was to precisely assess changes in α-syn levels in human neuroblastoma (SH-SY5Y) and melanoma (SK-MEL-2) cell lines following acute exposure to pesticides (rotenone, paraquat, maneb, and glyphosate) using Western blot and flow cytometry. These human cell lines express α-syn endogenously, and overexpression of α-syn (wild type or mutated A53T) can be obtained following recombinant adenoviral transduction. We found that endogenous α-syn levels in the SH-SY5Y neuroblastoma cell line were markedly increased by paraquat, and to a lesser extent by rotenone and maneb, but not by glyphosate. Rotenone also clearly increased endogenous α-syn levels in the SK-MEL-2 melanoma cell line. In the SH-SY5Y cell line, similar differences were observed in the α-syn adenovirus-transduced cells, with a higher increase of the A53T mutated protein. Paraquat markedly increased α-syn in the SK-MEL-2 adenovirus-transduced cell line, similarly for the wild-type or A53T proteins. The observed differences in the propensities of pesticides to increase α-syn levels are in agreement with numerous reports that indicate a potential role of exposure to certain pesticides in the development of Parkinson's disease. Our data support the hypothesis that pesticides can trigger some molecular events involved in this disease and also in malignant melanoma that consistently shows a significant but still unexplained association with Parkinson's disease.

Entities:  

Keywords:  Parkinson’s disease; malignant melanona.; neuroblastoma; pesticides; α-synuclein

Mesh:

Substances:

Year:  2013        PMID: 23535362     DOI: 10.1093/toxsci/kft076

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  15 in total

1.  Maneb-induced dopaminergic neuronal death is not affected by loss of mitochondrial complex I activity: results from primary mesencephalic dopaminergic neurons cultured from individual Ndufs4+/+ and Ndufs4-/- mouse embryos.

Authors:  Won-Seok Choi; Zhengui Xia
Journal:  Neuroreport       Date:  2014-12-03       Impact factor: 1.837

2.  Morus alba leaf extract mediates neuroprotection against glyphosate-induced toxicity and biochemical alterations in the brain.

Authors:  Olfa Rebai; Manel Belkhir; Adnen Boujelben; Sami Fattouch; Mohamed Amri
Journal:  Environ Sci Pollut Res Int       Date:  2017-02-28       Impact factor: 4.223

3.  Inhibition of Protein Ubiquitination by Paraquat and 1-Methyl-4-Phenylpyridinium Impairs Ubiquitin-Dependent Protein Degradation Pathways.

Authors:  Juliana Navarro-Yepes; Annadurai Anandhan; Erin Bradley; Iryna Bohovych; Bo Yarabe; Annemieke de Jong; Huib Ovaa; You Zhou; Oleh Khalimonchuk; Betzabet Quintanilla-Vega; Rodrigo Franco
Journal:  Mol Neurobiol       Date:  2015-09-26       Impact factor: 5.590

4.  Blood α-synuclein in agricultural pesticide handlers in central Washington State.

Authors:  Susan Searles Nielsen; Harvey Checkoway; Jing Zhang; Jonathan N Hofmann; Matthew C Keifer; Michael Paulsen; Federico M Farin; Travis J Cook; Christopher D Simpson
Journal:  Environ Res       Date:  2014-11-20       Impact factor: 6.498

5.  The role of the melanoma gene MC1R in Parkinson disease and REM sleep behavior disorder.

Authors:  Ziv Gan-Or; Noreen Mohsin; Simon L Girard; Jacques Y Montplaisir; Amirthagowri Ambalavanan; Stephanie Strong; Victoria Mallett; Sandra B Laurent; Cynthia V Bourassa; Michel Boivin; Melanie Langlois; Isabelle Arnulf; Birgit Högl; Birgit Frauscher; Christelle Monaca; Alex Desautels; Jean-François Gagnon; Ronald B Postuma; Patrick A Dion; Yves Dauvilliers; Nicolas Dupre; Roy N Alcalay; Guy A Rouleau
Journal:  Neurobiol Aging       Date:  2016-04-06       Impact factor: 4.673

6.  Is the risk of motor neuron disease increased or decreased after cancer? An Australian case-control study.

Authors:  Alex Stoyanov; Roger Pamphlett
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

7.  The Presence of Alpha-Synuclein in Skin from Melanoma and Patients with Parkinson's Disease.

Authors:  Ildefonso Rodriguez-Leyva; Erika Chi-Ahumada; Manuel Mejía; Juan P Castanedo-Cazares; William Eng; Sami K Saikaly; Juan Carrizales; Todd D Levine; Robert A Norman; Maria E Jimenez-Capdeville
Journal:  Mov Disord Clin Pract       Date:  2017-06-01

Review 8.  The associations between Parkinson's disease and cancer: the plot thickens.

Authors:  Danielle D Feng; Waijiao Cai; Xiqun Chen
Journal:  Transl Neurodegener       Date:  2015-10-26       Impact factor: 8.014

9.  Specific Effects of Chronic Dietary Exposure to Chlorpyrifos on Brain Gene Expression-A Mouse Study.

Authors:  Maria Michela Pallotta; Raffaele Ronca; Rosa Carotenuto; Immacolata Porreca; Mimmo Turano; Concetta Ambrosino; Teresa Capriglione
Journal:  Int J Mol Sci       Date:  2017-11-20       Impact factor: 5.923

Review 10.  Parkinson's Disease and Melanoma: Co-Occurrence and Mechanisms.

Authors:  Anindita Bose; Gregory A Petsko; David Eliezer
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.